Skip to main content

View full-text article in PMC

. 2022 Oct 20;20:475. doi: 10.1186/s12967-022-03691-2

Table 2.

five association metabolites passed all the sensitivity analyses

Description	P_{fixed-effect IVW}	P_MR-Egger	P_{Weighted-median}	P_MR-PRESSO	P_{MR-PRESSO Global}	P_{MR-Egger intercept}	P_{IVW. Q}
1-arachidonoylglycerophosphocholine for anxiety disorders diagnosed by psychiatrists	0.0042**	0.026*	0.0002***	0.0096**	0.149	0.338	0.207
androsterone sulfate for anxiety disorders diagnosed by psychiatrists	0.0065**	0.0185*	7.63 × 10^–5***	0.0136*	0.113	0.311	0.091
1-linoleoylglycerophosphoethanolamine for anxiety disorders diagnosed by general practitioners	0.002**	0.0148*	0.0001***	0.003**	0.366	0.146	0.408
1-eicosatrienoylglycerophosphocholine for anxiety disorders diagnosed by general practitioners	0.001**	0.0447*	0.116	0.0005***	0.696	0.440	0.670
epiandrosterone sulfate for self-reported anxiety	0.0028**	0.023*	0.0027**	0.007**	0.554	0.249	0.620

*p < 0.05

**p < 0.01

***p < 0.001;